Medicare billing address
CMS Medicare provider billing file
4403 Harrison Blvd Ste 3650Ogden, UT 84403
CMS public data · NPI 1922426782
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Stephen T Williams, M.D.
Specialty
Credential
M.D.
NPI
1922426782
Primary source state
UT
Data retrieval date
July 28, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Stephen T Williams, M.D. from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
4403 Harrison Blvd Ste 3650CMS Doctors & Clinicians file
4403 Harrison BlvdCMS Doctors & Clinicians file
700 S Hwy 99In the 2024 CMS provider billing file, this NPI had 138 Medicare beneficiaries and 25,020 total services. The average beneficiary age was 72, and the average HCC risk score was 1.6.
Total Medicare allowed amount
$423,636.26
Total Medicare payment amount
$332,936.66
Medicare beneficiaries
138
Total services
25,020
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hypertension
64%
CMS beneficiary-panel share
Hyperlipidemia
55%
CMS beneficiary-panel share
Chronic kidney disease
38%
CMS beneficiary-panel share
Osteoporosis
36%
CMS beneficiary-panel share
Mood disorders
27%
CMS beneficiary-panel share
Depression
25%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Injection, denosumab, 1 mg | 1,500 | $25.62 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 266 | $119.37 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 146 | $15.46 |
| Insertion of needle into vein for collection of blood sample | 108 | $7.84 |
| Administration of chemotherapy into vein, 1 hour or less | 66 | $108.28 |
| Injection of drug or substance under skin or into muscle | 60 | $13.49 |
| Administration of chemotherapy into vein, each additional hour | 31 | $24.85 |
| New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more | 22 | $158.73 |
| Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more | 17 | $171.37 |
| New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more | 14 | $209.96 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1922426782. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Methotrexate | Methotrexate Sodium | 225 | 590.1 | $8,326.13 |
| 2 | Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 188 | 475.2 | $7,928.49 |
| 3 | Prednisone | Prednisone | 79 | 151.8 | $587.15 |
| 4 | Allopurinol | Allopurinol | 69 | 178.6 | $892.80 |
| 5 | Folic Acid | Folic Acid | 58 | 165.2 | $475.74 |
| 6 | Alendronate Sodium | Alendronate Sodium | 51 | 124.8 | $352.14 |
| 7 | Methylprednisolone | Methylprednisolone | 31 | 31 | $266.20 |
| 8 | Meloxicam | Meloxicam | 27 | 51 | $140.11 |
| 9 | Teriparatide | Teriparatide | 26 | 26 | $70,461.58 |
| 10 | Tymlos | Abaloparatide | 20 | 20 | $51,816.70 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Medical school
University Of Texas Medical School At Houston
Graduation year
2014
Group/practice field
Ihc Health Services Inc
Telehealth reported
Yes
Secondary specialty fields reported by CMS: Rheumatology.
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.